August 20, 2017 5:25 PM ET

Biotechnology

Company Overview of Kolltan Pharmaceuticals, Inc.

Key Executives for Kolltan Pharmaceuticals, Inc.

NameBoard RelationshipsTitleAge
Gerald McMahon Ph.D.26 RelationshipsChief Executive Officer, President and Director62
Arthur G. Altschul Jr.40 RelationshipsCo-Founder and Chairman of the Board52
Joseph P. Schlessinger Ph.D.74 RelationshipsCo-Founder, Chairman of Scientific Advisory Board, Chief Scientist and Director72
Ronald A. Peck M.D.No RelationshipsChief Medical Officer and Senior Vice President of Clinical Development--
Yaron Hadari Ph.D.No RelationshipsVice President of Research--

Kolltan Pharmaceuticals, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Arthur G. Altschul Jr. 40 RelationshipsDiaz & Altschul Group LLC52
Gerald McMahon Ph.D. 26 RelationshipsKolltan Pharmaceuticals, Inc.62
Axel Bolte M.Sc., M.B.A. 37 RelationshipsHBM Partners Ltd.45
Joseph P. Schlessinger Ph.D. 74 RelationshipsPlexxikon Inc.72
K. Peter Hirth Ph.D. 87 RelationshipsTrovaGene, Inc.65
View All Board Members

Kolltan Pharmaceuticals, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Advisory Board Ph.D.Joseph P. Schlessinger74 Relationships8 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary$400.0K
400.0K
389.7K
Bonus
Not meaningful
Total Short Term Compensation
Not meaningful
Total Value of Options$400.0K
400.0K
18.7M
Compensation as of Fiscal Year 2013
Kolltan Pharmaceuticals, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Cellectar Biosciences, Inc. Announces Management Changes
August 18, 2017 9:00 PM ET
Isofol Medical AB (publ) Appoints Sven Erickson as Chief Commercial Officer
August 18, 2017 6:32 PM ET
Kane Biotech Inc. Announces Resignation of Sarah Prichard as Director
August 18, 2017 11:12 AM ET
RHS Limited Appoints Alwin Hui as Chief Commercial Officer
August 18, 2017 3:43 AM ET
Immunocellular Therapeutics, Ltd. Announces Resignation of Mark A. Schlossberg and Gregg A. Lapointe from the Board of Directors
August 17, 2017 8:32 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Kolltan Pharmaceuticals, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.